Patents by Inventor Xiongwei Cai

Xiongwei Cai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIMIDINYL TYROSINE KINASE INHIBITORS
    Publication number: 20230174511
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton’s tyrosine kinase and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: August 8, 2022
    Publication date: June 8, 2023
    Applicants: Viracta Therapeutics, Inc., Biogen MA Inc., Biogen MA Inc.
    Inventors: Brian T. HOPKINS, Timothy R. CHAN, Tracy J. JENKINS, Patrick CONLON, Xiongwei CAI, Michael HUMORA, Xianglin SHI, Ross A. MILLER, Andrew THOMPSON
  • PYRIMIDINYL TYROSINE KINASE INHIBITORS
    Publication number: 20210017155
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: February 27, 2020
    Publication date: January 21, 2021
    Inventors: Brian T. HOPKINS, Timothy R. CHAN, Tracy J. JENKINS, Patrick CONLON, Xiongwei CAI, Michael HUMORA, Xianglin SHI, Ross A. MILLER, Andrew THOMPSON
  • Pyrimidinyl tyrosine kinase inhibitors
    Patent number: 10618887
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: April 14, 2020
    Assignees: Sunesis Pharmaceuticals, Inc., Biogen MA Inc.
    Inventors: Brian T. Hopkins, Timothy R. Chan, Tracy J. Jenkins, Patrick Conlon, Xiongwei Cai, Michael Humora, Xianglin Shi, Ross A. Miller, Andrew Thompson
  • PYRIMIDINYL TYROSINE KINASE INHIBITORS
    Publication number: 20190047986
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: March 5, 2018
    Publication date: February 14, 2019
    Inventors: Brian T. HOPKINS, Timothy R. CHAN, Tracy J. JENKINS, Patrick CONLON, Xiongwei CAI, Michael HUMORA, Xianglin SHI, Ross A. MILLER, Andrew THOMPSON
  • Inhibitors of Bruton's tyrosine kinase
    Patent number: 10189817
    Abstract: The present invention provides a compound, solid forms, and compositions thereof, which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same. The present invention also provides methods of making provided compound and solid forms.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: January 29, 2019
    Assignee: BIOGEN MA INC.
    Inventors: Brian T. Hopkins, Xiongwei Cai, Timothy R. Chan, Patrick Conlon, Michael Humora, Tracy J. Jenkins, J. Michael Macphee, Xianglin Shi, Ross A. Miller, Andrew Thompson
  • INHIBITORS OF BRUTON'S TYROSINE KINASE
    Publication number: 20180291001
    Abstract: The present invention provides a compound, solid forms, and compositions thereof, which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same. The present invention also provides methods of making provided compound and solid forms.
    Type: Application
    Filed: January 19, 2018
    Publication date: October 11, 2018
    Inventors: Brian T. Hopkins, Xiongwei Cai, Timothy R. Chan, Patrick Conlon, Michael Humora, Tracy J. Jenkins, J. Michael Macphee, Xianglin Shi, Ross A. Miller, Andrew Thompson
  • Pyrimidinyl tyrosine kinase inhibitors
    Patent number: 9944622
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: April 17, 2018
    Assignees: Biogen MA Inc., Sunesis Pharmaceuticals, Inc.
    Inventors: Brian T. Hopkins, Timothy R. Chan, Tracy J. Jenkins, Patrick Conlon, Xiongwei Cai, Michael Humora, Xianglin Shi, Ross A. Miller, Andrew Thompson
  • INHIBITORS OF BRUTON'S TYROSINE KINASE
    Publication number: 20170114039
    Abstract: The present invention provides a compound, solid forms, and compositions thereof, which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same. The present invention also provides methods of making provided compound and solid forms.
    Type: Application
    Filed: May 27, 2016
    Publication date: April 27, 2017
    Inventors: Brian T. Hopkins, Xiongwei Cai, Timothy R. Chan, Patrick Conlon, Michael Humora, Tracy J. Jenkins, J. Michael Macphee, Xianglin Shi, Ross A. Miller, Andrew Thompson
  • PYRIMIDINYL TYROSINE KINASE INHIBITORS
    Publication number: 20160304494
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: June 29, 2016
    Publication date: October 20, 2016
    Inventors: Brian T. Hopkins, Timothy R. Chan, Tracy J. Jenkins, Patrick Conlon, Xiongwei Cai, Michael Humora, Xianglin Shi, Ross A. Miller, Andrew Thompson
  • Pyrimidinyl tyrosine kinase inhibitors
    Patent number: 9394277
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: July 19, 2016
    Assignees: Biogen MA Inc., Sunesis Pharmaceuticals, Inc.
    Inventors: Brian T. Hopkins, Patrick Conlon, Timothy R. Chan, Tracy J. Jenkins, Xiongwei Cai, Michael Humora, Xianglin Shi, Ross A. Miller, Andrew Thompson
  • Inhibitors of Bruton's tyrosine kinase
    Patent number: 9353087
    Abstract: The present invention provides a compound, solid forms, and compositions thereof, which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same. The present invention also provides methods of making provided compound and solid forms.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: May 31, 2016
    Assignees: Biogen MA Inc., Sunesis Pharmaceuticals, Inc.
    Inventors: Brian T. Hopkins, Xiongwei Cai, Timothy R. Chan, Patrick Conlon, Michael Humora, Tracy J. Jenkins, Michael J. Macphee, Xianglin Shi, Ross A. Miller, Andrew Thompson
  • PYRIMIDINYL TYROSINE KINASE INHIBITORS
    Publication number: 20150158843
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: June 7, 2013
    Publication date: June 11, 2015
    Inventors: Brian T. Hopkins, Patrick Conlon, Timothy R. Chan, Tracy J. Jenkins, Xiongwei Cai, Michael Humora, Xianglin Shi, Ross A. Miller, Andrew Thompson
  • INHIBITORS OF BRUTON'S TYROSINE KINASE
    Publication number: 20150126528
    Abstract: The present invention provides a compound, solid forms, and compositions thereof, which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same. The present invention also provides methods of making provided compound and solid forms.
    Type: Application
    Filed: June 7, 2013
    Publication date: May 7, 2015
    Inventors: Brian T. Hopkins, Xiongwei Cai, Timothy R. Chan, Patrick Conlon, Michael Humora, Tracy J. Jenkins, Michael J. Macphee, Xianglin Shi, Ross A. Miller, Andrew Thompson
  • Efficient process for the preparation of cabergoline and its intermediates
    Patent number: 7939665
    Abstract: This invention relates to a new and efficient process for the production of dopamine agonists such as Cabergoline and the intermediates thereof.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: May 10, 2011
    Assignee: Apotex Pharmachem Inc.
    Inventors: Zhi-Xian Wang, YuanQiang Li, Murali Kondamreddy, Xiongwei Cai
  • New and efficient process for the preperation of cabergoline and its intermediates
    Publication number: 20080275240
    Abstract: This invention relates to a new and efficient process for the production of dopamine agonists such as Cabergoline and the intermediates thereof.
    Type: Application
    Filed: May 4, 2007
    Publication date: November 6, 2008
    Inventors: Zhi-Xian Wang, YuanQiang Li, Murali Kondamreddy, Xiongwei Cai